SA company sets the stage for Asian expansion

Recent Posts

• bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 November 14, 2024
• SA company sets the stage for Asian expansion November 8, 2024
• bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development November 4, 2024
• bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung October 30, 2024
• bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement October 18, 2024